Heart failure remains a common diagnosis, especially in older individuals. It continues to be
associated with significant morbidity and mortality, but major advances in both diagnosis …

After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Abstract The 2017 ACC/AHA/Heart Failure Society of America (HFSA) heart failure (HF)
guidelines (1) reflect a focused update of the ACC/AHA 2013 HF guidelines (2) and include …

The classes of recommendations and levels of evidence in these guidelines were
determined and described according to the “Guidelines for the treatment of acute and …

Guidelines and Expert Consensus Documents produced by Task Forces, expert groups, or
consensus panels. The chosen experts in these writing panels are asked to provide …

The syndrome of heart failure (HF) is a common manifestation of the later stages of various
cardiovascular diseases, including coronary artery disease, hypertension, valvular disease …

The Task Force has been spearheading the initiative to standardize the lexicon of
cardiovascular medicine to enhance the use of clinical data, improve clinical …

Chronic heart failure (CHF) is associated with a heavy burden of disease for patients and
healthcare professionals. Quality of life and long-term prognosis for affected patients remain …

Background Several therapies are guideline‐recommended to reduce mortality in patients
with heart failure (HF) and reduced left ventricular ejection fraction, but the incremental …